ATE113035T1 - 1,4-dihydropyridin-derivate und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

1,4-dihydropyridin-derivate und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE113035T1
ATE113035T1 AT88103866T AT88103866T ATE113035T1 AT E113035 T1 ATE113035 T1 AT E113035T1 AT 88103866 T AT88103866 T AT 88103866T AT 88103866 T AT88103866 T AT 88103866T AT E113035 T1 ATE113035 T1 AT E113035T1
Authority
AT
Austria
Prior art keywords
vasodilatation
alkyl
pharmaceutical compositions
compositions containing
dihydropyridine derivatives
Prior art date
Application number
AT88103866T
Other languages
English (en)
Inventor
Hiroshi Matsui
Fumio Mutsumi-Ryo - Fukata
Takayoshi Mori
Nobuharu Kakeya
Kazuhiko Sandan Osa-Cho Kitao
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Application granted granted Critical
Publication of ATE113035T1 publication Critical patent/ATE113035T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT88103866T 1987-03-12 1988-03-10 1,4-dihydropyridin-derivate und diese enthaltende pharmazeutische zusammensetzungen. ATE113035T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62057717A JPH0688973B2 (ja) 1987-03-12 1987-03-12 １，４−ジヒドロピリジン誘導体

Publications (1)

Publication Number Publication Date
ATE113035T1 true ATE113035T1 (de) 1994-11-15

Family

ID=13063696

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88103866T ATE113035T1 (de) 1987-03-12 1988-03-10 1,4-dihydropyridin-derivate und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (10)

Country Link
US (1) US4937242A (de)
EP (1) EP0289746B1 (de)
JP (1) JPH0688973B2 (de)
KR (1) KR960009427B1 (de)
AT (1) ATE113035T1 (de)
AU (1) AU610130B2 (de)
CA (1) CA1337764C (de)
DE (1) DE3851856T2 (de)
DK (1) DK174867B1 (de)
ES (1) ES2061534T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
US5166148A (en) * 1990-07-09 1992-11-24 The Du Pont Merck Pharmaceutical Company 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
IL109220A0 (en) * 1993-04-05 1994-07-31 Synaptic Pharma Corp Dihydropyridines and new uses thereof
US6211198B1 (en) 1993-04-05 2001-04-03 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
US5767131A (en) * 1993-04-05 1998-06-16 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
AU8142794A (en) * 1993-11-17 1995-06-06 Byk Nederland Bv Use of substituted 1,4-dihydropyridine to reduce intraocular pressure
ES2317650T3 (es) * 1996-10-28 2009-04-16 Senju Pharmaceutical Co., Ltd. Farmacos para mejorar trastornos circulatorios oculares.
US6528516B1 (en) * 1998-07-16 2003-03-04 Trustees Of The University Of Pennsylvania, The Center For Technology Transfer Methods for reducing intraocular pressure using A3 adenosine receptor antagonists
EP1179345B1 (de) 1999-01-29 2009-04-08 Senju Pharmaceutical Co., Ltd. Inhibitoren einer augendruck-erhöhung durch laserbestrahlung, die 1,4-dihydropyridin-derivate enthalten
EP1181934B1 (de) * 1999-04-14 2004-10-06 Senju Pharmaceutical Co., Ltd. 1,4-dihydropyridinderivate als Inhibitoren einer Sehunterfunktion, hervorgerufen durch eine Sehnervzellenverletzung, die durch andere Faktoren als optischen Durchblutungstörungen induziert wird.
US6566359B1 (en) 2002-05-20 2003-05-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs
KR101419213B1 (ko) * 2013-05-22 2014-07-14 인하대학교 산학협력단 메틸 5-시아노-6-｛[2-(4-메톡시페닐)-2-옥소에틸]술파닐｝-2-메틸-4-(2-티에닐)-1,4-디하이드로-3-피리딘카르복실레이트 화합물을 유효성분으로 함유하는 피부 미백용 조성물 및 이의 용도

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
US3951993A (en) * 1972-03-06 1976-04-20 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives and process for their preparation
US3950336A (en) * 1972-03-06 1976-04-13 Bayer Aktiengesellschaft 2,6-diamino-1,4-dihydropyridine derivatives
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
US3959296A (en) * 1972-06-10 1976-05-25 Bayer Aktiengesellschaft 1,4-Dihydropyridines
US3951991A (en) * 1972-08-31 1976-04-20 Bayer Aktiengesellschaft 4-Aryl-6-amino-3,4-dihydropyrid-2-one-3,5-dicarboxylic acid ester
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DE3124673A1 (de) * 1981-06-24 1983-01-13 Bayer Ag, 5090 Leverkusen Subsituierte 2-amino-pyridinderivate, verfahren zu ihrer herstellung, ihre verwendung in arzneimitteln, sowie deren herstellung
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
HU192166B (en) * 1982-08-06 1987-05-28 Banyu Pharma Co Ltd Process for producing 2-carbamoyl-oxy-alkyl-1,4-dihydro-pyridine derivatives
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
AU561213B2 (en) * 1983-06-02 1987-04-30 Teijin Limited 1, 4-dihydropyridine derivative
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
GB8401288D0 (en) * 1984-01-18 1984-02-22 Pfizer Ltd Therapeutic agents
JPS6157556A (ja) * 1984-08-29 1986-03-24 Teijin Ltd １，４−ジヒドロピリジン誘導体その製造法およびそれを有効成分とする薬剤
JPS61137861A (ja) * 1984-10-26 1986-06-25 バイエル・アクチエンゲゼルシヤフト １，４−ジヒドロピリジン−ヒドロキシアミン類
DE3514865A1 (de) * 1985-04-25 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
AU610130B2 (en) 1991-05-16
EP0289746A3 (en) 1989-09-20
KR960009427B1 (ko) 1996-07-19
JPH0688973B2 (ja) 1994-11-09
KR890002102A (ko) 1989-04-08
DK129688D0 (da) 1988-03-10
DK174867B1 (da) 2004-01-05
DE3851856D1 (de) 1994-11-24
EP0289746B1 (de) 1994-10-19
EP0289746A2 (de) 1988-11-09
CA1337764C (en) 1995-12-19
JPS63225355A (ja) 1988-09-20
DE3851856T2 (de) 1995-03-16
DK129688A (da) 1988-09-13
ES2061534T3 (es) 1994-12-16
AU1251988A (en) 1988-09-15
US4937242A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
HU912731D0 (en) Process for producing new substituted guanidine derivatives and pharmaceutical preparatives containing said compounds
DE68913487D1 (de) Piperazine-Derivate.
ATE209645T1 (de) Neue verbindung, verfahren zu ihrer herstellung und antitumormittel
DE3851856D1 (de) 1,4-Dihydropyridin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE69001111D1 (de) Antikrebs-zusammensetzung.
DK601283A (da) Pyridinderivater
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
DK0420224T3 (da) Anthihepatopatisk middel
ATE27455T1 (de) Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
KR910011839A (ko) 이미다졸리딘 유도체, 그의 제조 방법 및 이를 함유하는 살충제
ATE97898T1 (de) Antitumor-substanz, verfahren zu deren herstellung und diese enthaltende antikrebsmittel.
ATE131480T1 (de) Pyrimidoindolderivate und verfahren zu ihrer herstellung
KR910006217A (ko) 디히드로카페인산 유도체 및 이를 함유하는 약학제제
DE3580685D1 (de) Benzoxathiin-derivate, verfahren zu deren herstellung und pharmazeutische zusammenstellungen.
JPS6429359A (en) 1,4-dihydropyridine derivative and production thereof
DE60014629D1 (de) 1,4-dihydropyridinderivate als Inhibitoren einer Sehunterfunktion, hervorgerufen durch eine Sehnervzellenverletzung, die durch andere Faktoren als optischen Durchblutungstörungen induziert wird.
MY104164A (en) Heterocyclic compounds.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time